Humana Inc. (HUM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Humana Inc.

    NYSE: HUM · Real-Time Price · USD
    283.62
    27.00 (10.52%)
    At close: Oct 03, 2025, 3:59 PM
    285.00
    0.49%
    After-hours: Oct 03, 2025, 07:57 PM EDT

    Humana Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 123.11B 120.26B 117.76B 115.01B 112.04B 109.24B 106.37B 102.35B 98.73B 95.64B 92.87B 91.48B 89.38B 86.37B 83.06B 81.07B 80.45B 78.89B
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 123.11B 120.26B 117.76B 115.01B 112.04B 109.24B 106.37B 102.35B 98.73B 95.64B 92.87B 91.48B 89.38B 86.37B 83.06B 81.07B 80.45B 78.89B
    Operating Income
    		 2.22B 2.4B 1.72B 1.99B 2.44B 2.78B 3.38B 3.9B 4.1B 3.96B 3.57B 3.58B 3.92B 3.53B 3.35B 2.96B 3.08B 4.92B
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 2.22B 2.4B 1.72B 1.99B 2.44B 2.78B 3.38B 3.9B 4.1B 3.96B 3.57B 3.58B 3.92B 3.53B 3.35B 2.96B 3.08B 4.92B
    Net Income
    		 1.58B 1.71B 1.21B 1.36B 1.71B 1.99B 2.49B 3.02B 3.38B 3.12B 2.81B 2.81B 3.14B 3.04B 2.93B 2.67B 2.48B 3.72B
    Selling & General & Admin
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.6B 4.72B 6.73B 9.79B 9.7B 9.94B
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 120.89B 117.86B 116.04B 113.02B 109.6B 106.46B 102.99B 98.45B 94.63B 91.68B 89.3B 87.91B 82.86B 78.11B 72.98B 68.32B 67.67B 64.02B
    Operating Expenses
    		 120.89B 117.86B 116.04B 113.02B 109.6B 106.46B 102.99B 98.45B 94.63B 91.68B 89.3B 87.91B 85.47B 82.83B 79.71B 78.12B 77.38B 73.97B
    Interest Expense
    		 650M 661M 660M 642M 587M 539M 493M 455M 443M 424M 401M 384M 370M 348M 326M 307M 294M 291M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 120.89B 117.86B 116.04B 113.02B 109.6B 106.46B 102.99B 98.45B 94.63B 91.68B 89.3B 87.91B 85.47B 82.83B 79.71B 78.12B 77.38B 73.97B
    Income Tax Expense
    		 524M 568M 413M 554M 655M 728M 836M 853M 704M 835M 762M 769M 782M 538M 485M 358M 688M 1.29B
    Shares Outstanding (Basic)
    		 120.54M 120.41M 120.41M 120.41M 120.44M 120.98M 122.46M 123.43M 124.57M 125M 125.64M 126.57M 126.52M 126.94M 128.61M 128.52M 128.69M 128.93M
    Shares Outstanding (Diluted)
    		 120.75M 120.76M 120.76M 120.76M 120.67M 121.27M 122.46M 123.98M 125.11M 125.56M 125.64M 127.36M 127.08M 127.47M 128.61M 129.25M 129.39M 129.55M
    EPS (Basic)
    		 13.07 14.19 10.01 11.34 14.09 16.15 19.93 24.23 26.93 24.73 22.15 22.16 24.63 23.70 22.79 20.83 19.05 28.30
    EPS (Diluted)
    		 13.03 14.15 9.96 11.30 14.03 16.06 19.82 24.12 26.80 24.62 22.04 22.05 24.50 23.57 22.67 20.71 18.92 28.12
    EBITDA
    		 3.78B 4B 3.35B 3.6B 3.98B 4.26B 4.79B 5.25B 5.42B 5.24B 4.81B 4.79B 5.08B 4.63B 4.39B 3.94B 4.03B 5.85B
    EBIT
    		 2.87B 3.06B 2.38B 2.63B 3.03B 3.32B 3.88B 4.36B 4.54B 4.39B 3.97B 3.96B 4.29B 3.88B 3.68B 3.26B 3.37B 5.21B
    Depreciation & Amortization
    		 909M 941M 968M 966M 958M 941M 917M 896M 875M 858M 845M 822M 789M 750M 713M 679M 659M 639M

    Add to Watchlist